20 Stocks Moving in Wednesday's Pre-Market Session

Gainers

• Puxin Limited NEW rose 52.1% to $0.6901 in pre-market trading after dipping 24% on Tuesday.
• Jasper Therapeutics, Inc. JSPR rose 38% to $9.95 in pre-market trading. Oppenheimer initiated coverage on Jasper Therapeutics with an Outperform rating and announced a price target of $21.
• Waitr Holdings Inc WTRH rose 26% to $1.01 in pre-market trading after Morgan Stanley reported a 10.3% passive stake in the company.
• Kintara Therapeutics, Inc. KTRA rose 16.1% to $1.11 in pre-market trading after climbing around 15% on Tuesday.
• RLX Technology Inc RLX rose 14% to $5.29 in pre-market trading after declining around 5% on Tuesday.
• Koss Corporation KOSS rose 13.3% to $21.74 in pre-market trading after jumping 25% on Tuesday.
• Generation Income Properties, Inc. GIPR shares rose 8.2% to $8.89 in pre-market trading after climbing 12% on Tuesday.
• DatChat, Inc. DATS shares rose 7.3% to $16.10 in pre-market trading after gaining over 19% on Tuesday.
• Vistra Corp. VST shares rose 7% to $19.08 in pre-market trading after the company announced a $2 billion buyback.
• Sentage Holdings Inc. SNTG rose 5.8% to $2.74 in pre-market trading after climbing over 18% on Tuesday.
• SAP SE SAP rose 5.3% to $141.72 in pre-market trading after the company announced preliminary Q3 financial results and raised its FY21 guidance.
• Infosys Limited INFY rose 5.1% to $23.00 in pre-market trading following quarterly results.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Neuronetics, Inc. STIM shares fell 26.9% to $4.68 in pre-market trading after the company lowered its sales guidance. BTIG downgraded Neuronetics from Buy to Neutral.
• Regulus Therapeutics Inc. RGLS shares fell 25% to $0.57 in pre-market trading after the company announced a strategic prioritization of its next-generation candidate, RGLS8429, for the treatment of ADPKD. The company's previous ADPKD candidate, RGLS4326, will no longer be advanced.
• Cytosorbents Corporation CTSO shares fell 9.8% to $6.25 in pre-market trading after the company reported preliminary Q3 results and received full FDA Investigational Device Exemption approval to begin US STAR-D trial on apixaban and rivaroxaban removal by DrugSorb-ATR antithrombotic removal system during urgent cardiothoracic surgery.
• Nutriband Inc. NTRB fell 8.7% to $8.86 in pre-market trading. Nutriband shares jumped 31% on Tuesday after the company announced it signed an exclusive manufacturing agreement for Diocheck visual COVID-19 antibody indicator patch.
• NRx Pharmaceuticals, Inc. NRXP fell 7.8% to $10.06 in pre-market trading. NRX Pharmaceuticals shares jumped 61% on Tuesday after the company announced progress on the worldwide commercial scale development of ZYESAMI.
• Apollo Endosurgery, Inc. APEN fell 7.6% to $7.84 in pre-market trading after the company reported pricing of $65 million public offering of common stock.
• ZIVO Bioscience, Inc. ZIVO fell 6.5% to $4.19 in pre-market trading after gaining over 18% on Tuesday.
• CRISPR Therapeutics AG CRSP shares fell 5.8% to $96.70 in pre-market trading after the company reported results from its Phase 1 CARBON trial of CTX110 in relapsed or refractory CD19+ B-cell malignancies.